Kaposi’s sarcoma-associated herpesvirus viral interferon regulatory factor-2 inhibits type 1 interferon signalling by targeting interferon-stimulated gene factor-3

References

1. Aresté C., Blackbourn D. J. 2009; Modulation of the immune system by Kaposi’s sarcoma-associated herpesvirus. Trends Microbiol 17:119–129 [View Article][PubMed]
   [Google Scholar]
2. Aresté C., Mutocheluh M., Blackbourn D. J. 2009; Identification of caspase-mediated decay of interferon regulatory factor-3, exploited by a Kaposi sarcoma-associated herpesvirus immunoregulatory protein. J Biol Chem 284:23272–23285 [View Article][PubMed]
   [Google Scholar]
3. Bouvard V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., Benbrahim-Tallaa L., Guha N., Freeman C. et al.& other authors ( 2009; A review of human carcinogens – part B: biological agents. Lancet Oncol 10:321–322 [View Article][PubMed]
   [Google Scholar]
4. Burýsek L., Pitha P. M. 2001; Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase. J Virol 75:2345–2352 [View Article][PubMed]
   [Google Scholar]
5. Burysek L., Yeow W. S., Pitha P. M. 1999; Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2). J Hum Virol 2:19–32[PubMed]
   [Google Scholar]
6. Chang Y., Cesarman E., Pessin M. S., Lee F., Culpepper J., Knowles D. M., Moore P. S. 1994; Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 266:1865–1869 [View Article][PubMed]
   [Google Scholar]
7. Chatterjee M., Osborne J., Bestetti G., Chang Y., Moore P. S. 2002; Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science 298:1432–1435 [View Article][PubMed]
   [Google Scholar]
8. Cunningham C., Barnard S., Blackbourn D. J., Davison A. J. 2003; Transcription mapping of human herpesvirus 8 genes encoding viral interferon regulatory factors. J Gen Virol 84:1471–1483 [View Article][PubMed]
   [Google Scholar]
9. Fuld S., Cunningham C., Klucher K., Davison A. J., Blackbourn D. J. 2006; Inhibition of interferon signaling by the Kaposi’s sarcoma-associated herpesvirus full-length viral interferon regulatory factor 2 protein. J Virol 80:3092–3097 [View Article][PubMed]
   [Google Scholar]
10. Gao S. J., Boshoff C., Jayachandra S., Weiss R. A., Chang Y., Moore P. S. 1997; KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene 15:1979–1985 [View Article][PubMed]
    [Google Scholar]
11. Gauzzi M. C., Velazquez L., McKendry R., Mogensen K. E., Fellous M., Pellegrini S. 1996; Interferon-α-dependent activation of Tyk2 requires phosphorylation of positive regulatory tyrosines by another kinase. J Biol Chem 271:20494–20500 [View Article][PubMed]
    [Google Scholar]
12. Krishnan H. H., Naranatt P. P., Smith M. S., Zeng L., Bloomer C., Chandran B. 2004; Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi’s sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J Virol 78:3601–3620 [View Article][PubMed]
    [Google Scholar]
13. Li M., Damania B., Alvarez X., Ogryzko V., Ozato K., Jung J. U. 2000; Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor. Mol Cell Biol 20:8254–8263 [View Article][PubMed]
    [Google Scholar]
14. Lubyova B., Pitha P. M. 2000; Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors. J Virol 74:8194–8201 [View Article][PubMed]
    [Google Scholar]
15. Morrison J. M., Racaniello V. R. 2009; Proteinase 2A^pro is essential for enterovirus replication in type I interferon-treated cells. J Virol 83:4412–4422 [View Article][PubMed]
    [Google Scholar]
16. Randall R. E., Goodbourn S. 2008; Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89:1–47 [View Article][PubMed]
    [Google Scholar]
17. Rezaee S. A., Cunningham C., Davison A. J., Blackbourn D. J. 2006; Kaposi’s sarcoma-associated herpesvirus immune modulation: an overview. J Gen Virol 87:1781–1804 [View Article][PubMed]
    [Google Scholar]
18. Schmidt K., Wies E., Neipel F. 2011; Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 3 inhibits gamma interferon and major histocompatibility complex class II expression. J Virol 85:4530–4537 [View Article][PubMed]
    [Google Scholar]
19. Shin Y. C., Nakamura H., Liang X., Feng P., Chang H., Kowalik T. F., Jung J. U. 2006; Inhibition of the ATM/p53 signal transduction pathway by Kaposi’s sarcoma-associated herpesvirus interferon regulatory factor 1. J Virol 80:2257–2266 [View Article][PubMed]
    [Google Scholar]
20. Wies E., Hahn A. S., Schmidt K., Viebahn C., Rohland N., Lux A., Schellhorn T., Holzer A., Jung J. U., Neipel F. 2009; The Kaposi’s sarcoma-associated herpesvirus-encoded vIRF-3 inhibits cellular IRF-5. J Biol Chem 284:8525–8538 [View Article][PubMed]
    [Google Scholar]
21. Zimring J. C., Goodbourn S., Offermann M. K. 1998; Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. J Virol 72:701–707[PubMed]
    [Google Scholar]